@article{balavoine:hal-03292696, TITLE = {{Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug}}, AUTHOR = {Balavoine, Fabrice and Azizi, Michel and Bergerot, Damien and de Mota, Nadia and Patouret, Remi and Roques, Bernard P. and Llorens-Cortes, Catherine}, URL = {https://cnrs.hal.science/hal-03292696}, JOURNAL = {{Clinical Pharmacokinetics}}, PUBLISHER = {{Springer Verlag}}, VOLUME = {53}, NUMBER = {4}, PAGES = {385-395}, YEAR = {2014}, DOI = {10.1007/s40262-013-0125-y}, KEYWORDS = {RENIN-ANGIOTENSIN SYSTEM ; BLOOD-PRESSURE ; VASOPRESSIN RELEASE ; ALDOSTERONE SYSTEM ; HYPERTENSIVE-RATS ; BRAIN ; BLOCKADE ; SITE ; IDENTIFICATION}, HAL_ID = {hal-03292696}, HAL_VERSION = {v1}, }